{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:08:38Z","timestamp":1766441318375},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Intensiva"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.medin.2010.09.012","type":"journal-article","created":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T09:29:39Z","timestamp":1294392579000},"page":"442-445","source":"Crossref","is-referenced-by-count":5,"title":["Tratamiento de necr\u00f3lisis epid\u00e9rmica t\u00f3xica con ciclosporina A"],"prefix":"10.1016","volume":"35","author":[{"given":"A. Fern\u00e1ndez","family":"Carmona","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D\u00edaz","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Olivencia","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Garz\u00f3n","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Carlos Fr\u00edas","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L. Ballesteros","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medin.2010.09.012_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00134-009-1659-1","article-title":"Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes","volume":"36","author":"Struck","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.medin.2010.09.012_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave","year":"2005","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.medin.2010.09.012_bib0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4103\/0378-6323.57729","article-title":"Outcome of Stevens Johnson syndrome and toxic epidermal necrolysis treated with corticosteroids","volume":"75","author":"Rijal","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.medin.2010.09.012_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.139.1.26","article-title":"Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases","volume":"139","author":"Prins","year":"2003","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.medin.2010.09.012_bib0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1526-0968.2002.00409.x","article-title":"Plasma exchange in patients with toxic epidermal necrolysis","volume":"6","author":"Bamichas","year":"2002","journal-title":"Ther Apher."},{"key":"10.1016\/j.medin.2010.09.012_bib0030","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.medin.2010.09.012_bib0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1346-8138.2009.00616.x","article-title":"Toxic epidermal necrolysis successfully treated with etanercept","volume":"36","author":"Gubinelli","year":"2009","journal-title":"Dermatol."},{"key":"10.1016\/j.medin.2010.09.012_bib0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","article-title":"Treatment of toxic epidermal necrolysis with cyclosporin A","volume":"48","author":"Ar\u00e9valo","year":"2000","journal-title":"J Trauma."},{"key":"10.1016\/j.medin.2010.09.012_bib0045","doi-asserted-by":"crossref","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Ma\u00eetre B, Revuz J. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. [en prensa] 2010.","DOI":"10.1111\/j.1365-2133.2010.09863.x"},{"key":"10.1016\/j.medin.2010.09.012_bib0050","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immunol."},{"key":"10.1016\/j.medin.2010.09.012_bib0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.medin.2010.09.012_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archderm.136.3.323","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?","volume":"136","author":"Garcia-Doval","year":"2000","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.medin.2010.09.012_bib0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","article-title":"Long-term follow-up of patients treated for toxic epidermal necrolysis","volume":"27","author":"Oplatek","year":"2006","journal-title":"J Burn Care Res."},{"key":"10.1016\/j.medin.2010.09.012_bib0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2005.11.012","article-title":"Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: Our current understanding","volume":"6","author":"French","year":"2006","journal-title":"Int Immunopharmacol."}],"container-title":["Medicina Intensiva"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210569110002780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210569110002780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T17:23:08Z","timestamp":1559928188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210569110002780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0210569110002780"],"URL":"https:\/\/doi.org\/10.1016\/j.medin.2010.09.012","relation":{},"ISSN":["0210-5691"],"issn-type":[{"value":"0210-5691","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}